Content by Memorial Sloan Kettering Cancer Center

|3 min read

New Research Suggests How to Improve Effectiveness of KRAS Inhibitors in Pancreatic Cancer

New research in mouse models has uncovered a new mechanism of resistance to KRAS inhibitors
|2 min read

Epigenetic Combo Therapy Shows Promise Against Rare Sarcomas

The team’s next step is to introduce immunotherapy to treat soft tissue sarcomas
|2 min read

New KRAS-Targeting Cancer Vaccine Safe, Immunogenic in Trials

Off-the-shelf vaccines are as efficacious as mRNA vaccines and are cheaper to produce and administer
|5 min read

Can Chromosomal Instability Drive Epigenetic Alterations in Cancer Cells?

Sequestration of chromosomes into micronuclei disrupts the organization of chromatin and triggers epigenetic dysregulation
|5 min read

Study Identifies Biomarker That May Help Predict Benefits of Immunotherapy

The findings pave the way for prospective clinical trials designed to test whether this biomarker can improve outcomes
|3 min read

Learning How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The results help explain why some tumors do not respond to immunotherapy and suggest ways to improve it
Page 1 of 1